Holzinger Anita, Loffler Watter, Muller Peter, Priebe Stefan, Angermeyer Matthias C
Department of Psychiatry, University of Leipzig, Johannisallee 20, 04317 Leipzig, Germany.
J Nerv Ment Dis. 2002 Sep;190(9):597-603. doi: 10.1097/01.NMD.0000030524.45210.FD.
This study investigates subjective illness theories of patients with schizophrenia, how they define their health problem, what they assume causes their illness and which course of illness they expect. The predictive value of those theories for patients' compliance with antipsychotic medication is tested. A problem-centered interview was conducted with 77 schizophrenic patients at discharge from inpatient or day hospital treatment. All patients were on clozapine treatment. Interviews were analyzed by means of computer-assisted content analysis. In addition, potential determinants of compliance were assessed using the 9th version of the Present State Examination, the UKU side effect rating scale, a checklist for patients' evaluations of the effect of psychotropic drugs, and a helping alliance scale. Compliance with medication was assessed by interviewing patients at discharge and three months later. Only slightly more than one half of the patients considered themselves mentally ill. They tended to endorse psychosocial causes more frequently as compared with biological causes. Slightly more than 25% of the patients each expected an improvement of the illness, a reoccurrence of the acute psychosis, or a chronic course. Whereas the quality of the helping alliance, delusion of grandiosity, and attitude toward psychotropic drugs proved to have an influence on patients' compliance with antipsychotic treatment, the three components of subjective illness theory (definition as mental illness, assumed etiology, and prognosis) did not have a statistically significant influence. Subjective illness theories vary in patients with schizophrenia. Although they might reflect different styles of coping with the illness, there is no evidence that they directly determine compliance with medication. Patients' views of the helping alliance and attitudes toward drugs should be considered in predicting compliance with antipsychotic medication.
本研究调查了精神分裂症患者的主观疾病理论,他们如何界定自己的健康问题,认为自己的疾病是由什么引起的,以及期望疾病会有怎样的病程。测试了这些理论对患者遵医嘱服用抗精神病药物的预测价值。对77名从住院或日间医院治疗出院的精神分裂症患者进行了以问题为中心的访谈。所有患者均接受氯氮平治疗。访谈通过计算机辅助内容分析进行分析。此外,使用第九版《目前状态检查》、UKU副作用评定量表、患者对精神药物疗效评估清单以及帮助联盟量表评估了遵医嘱的潜在决定因素。通过在出院时和三个月后对患者进行访谈来评估药物依从性。只有略多于一半的患者认为自己患有精神疾病。与生物学原因相比,他们更倾向于认可社会心理原因。略多于25%的患者分别期望病情好转、急性精神病复发或病程呈慢性。虽然帮助联盟的质量、夸大妄想和对精神药物的态度被证明对患者遵医嘱接受抗精神病治疗有影响,但主观疾病理论的三个组成部分(界定为精神疾病、假定病因和预后)没有统计学上的显著影响。精神分裂症患者的主观疾病理论各不相同。尽管它们可能反映了应对疾病的不同方式,但没有证据表明它们直接决定药物依从性。在预测抗精神病药物的依从性时,应考虑患者对帮助联盟的看法和对药物的态度。